Acorda Therapeutics Announces New Agreement with Catalent for Long-Term Global Supply of INBRIJA®
Significant reduction in minimum purchase requirements 2026 manufacturing capacity expansion expected to result in further…
Month: January 2023
LTC Invests $128 Million in 12 Assisted Living/Memory Care Properties in North Carolina
WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–LTC Properties, Inc. (NYSE: LTC) a real estate investment trust that primarily…
New Mountain Finance Corporation Schedules its Fourth Quarter and Year Ended December 31, 2022 Earnings Release and Conference Call
NEW YORK–(BUSINESS WIRE)–New Mountain Finance Corporation (Nasdaq: NMFC) (“New Mountain” or “the Company”) announced today…
USANA Health Sciences Provides Preliminary Fiscal Year 2022 Results and Issues Initial Fiscal Year 2023 Outlook
SALT LAKE CITY–(BUSINESS WIRE)–USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary fiscal year 2022…
Semtech Corporation and Sierra Wireless Announce Termination of the Waiting Period Under the HSR Act
Closing of the Transaction is now Expected to Occur on or About January 12, 2023…
MSCI Upgrades UGI Corporation’s ESG Rating to “AAA”
VALLEY FORGE, Pa.–(BUSINESS WIRE)–#AAA–UGI Corporation (NYSE: UGI) announced today that in December 2022 it received…
TYLin Welcomes Stephen Cayea as Chief Information Officer
SAN FRANCISCO–(BUSINESS WIRE)–#tylin–TYLin, a globally recognized full-service infrastructure consulting firm, is pleased to announce that…
Merchants & Marine Bank Taps Trammell for Chief Operations Officer Post
PASCAGOULA, Miss.–(BUSINESS WIRE)–The Board of Directors of Merchants & Marine Bank, a wholly owned subsidiary…
Atmos Energy Corporation to Host Fiscal 2023 First Quarter Earnings Conference Call on February 8, 2023
DALLAS–(BUSINESS WIRE)–Atmos Energy Corporation (NYSE: ATO) will host a conference call on Wednesday, February 8,…
UPDATE — Noema Pharma to Attend and Present at 41st Annual J.P. Morgan Healthcare Conference in San Francisco
BASEL, Switzerland and BOSTON, Jan. 05, 2023 (GLOBE NEWSWIRE) — Noema Pharma, a clinical-stage biotech…
MAT Act Signed Into Law, NABP Applauds Benefits for Overdose Prevention and Recovery Support
MOUNT PROSPECT, IL, Jan. 05, 2023 (GLOBE NEWSWIRE) — Shortly before the new year, President…
Get the Razer Edge 5G — only from Verizon — starting Jan. 26 and get on the cutting-edge of gaming
Introducing the ultimate Android gaming handheld. The 5G gaming era begins now! LAS VEGAS, Jan….
Voltus Helps Mitigate the Impact of Winter Storm Elliott by Providing 11.6 GWh of Electricity Reduction Across the US and Canada
Voltus customers provided critical grid relief as extreme weather and record low temperatures impacted millions…
Parallel Advisors Partners with Golden Gate Capital on Recapitalization
Strategic Investment by Golden Gate Capital Will Accelerate Organic Growth and M&A Strategy, Including Acquisition…
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Avaya Holdings Corp. (AVYA)
SAN DIEGO–(BUSINESS WIRE)–$AVYA #AVYA—The Class: Robbins LLP informs investors that a shareholder filed a class…
OneStream Continues Momentum in the Fourth Quarter of 2022 with Strong Growth and Expanded Customer Base
CPM Software provider reports over $300M in Annual Recurring Revenue, up 50% year-over-year BIRMINGHAM, Mich.–(BUSINESS…
VALNEVA – Declaration of shares and voting rights: December 31, 2022
VALNEVA Declaration of shares and voting rightsDecember 31, 2022 __________________________________________________________________________________________ Company name: VALNEVARegistered office: 6…
Mendus AB: Mendus announces request of first tranche of convertible loan from Negma Group
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
PersonalRX Earns URAC Accreditation in Mail Service Pharmacy
The Designation Demonstrates the Highest Level of Commitment to Quality Healthcare EAST RUTHERFORD, N.J., Jan….
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
TORONTO, Jan. 05, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB:…